Abstract
BackgroundThe active substance of Remicade is infliximab. It is a chimeric human-murine monoclonal antibody directed against tumour necrosis factor α (TNFα), manufactured from a recombinant cell line. Remicade is presented...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have